"An essential resource"
Buck Rogers, PhD
Washington University in St. Louis
"Cancer Biotherapy and Radiopharmaceuticals publishes the most up-to-date articles advancing the field of cancer research."
Dr. Smriti Krishna, MPhil, PhD
Senior Research Scientist
School of Medicine & Dentistry
James Cook University
“Cancer Biotherapy and Radiopharmaceuticals is a ‘must read’ for those of us involved in translational ‘bench-to-bedside’ research in the field of biotherapy. It is the only journal with the specific focus of cancer biotherapy, and is inclusive of monoclonal antibodies, cytokines, gene therapy, cell-based therapies and other forms of immunotherapies.”
Robert O. Dillman, MD, FACP
Medical Director, Hoag Cancer Center
Newport Beach, CA
“Cancer Biotherapy and Radiopharmaceuticals is an invaluable resource for investigators to publish cutting-edge research in the emerging fields of radioimmunotherapy and biologic approaches for the diagnosis and treatment of cancer.”
Alan L. Epstein, MD, PhD
University of Southern California
Keck School of Medicine
Los Angeles, CA
The views, opinions, findings, conclusions and recommendations set forth in any
Journal article are solely those of the authors of those articles and do not necessarily
reflect the views, policy or position of the Journal, its Publisher, its editorial
staff or any affiliated Societies and should not be attributed to any of them.